Serum 25-hydroxyvitamin D3 and D2 and non-clinical psychotic experiences in childhood

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Tolppanen, Anna Maija ^a   Sayers, Adrian ^a   Fraser, William D ^b   Lewis, Glyn ^a   Zammit, Stanley ^a,c   McGrath, John ^d   Lawlor, Debbie A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYERGOCALCIFEROL; CALCIFEDIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHATE;

ARTICLE; BLOOD LEVEL; CHILD; CHILDHOOD; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIST; PSYCHOSIS; RISK ASSESSMENT; SCHOOL CHILD;

25-HYDROXYVITAMIN D 2; ADOLESCENT; ADULT; CALCIFEDIOL; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS;

EID: 84864687241     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041575     Document Type: Article

References (42)

1. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L, (2009) A systematic review and meta-analysis of the psychosis continuum: Evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 39: 179-195.
2. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, et al. (2000) Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study. Arch Gen Psychiatry 57: 1053-1058.
3. Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J, (2005) The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol 44: 181-191.
4. Kelleher I, Cannon M, (2011) Psychotic-like experiences in the general population: Characterizing a high-risk group for psychosis. Psychol Med 41: 1-6.
5. McGrath J, Brown A, St Clair D, (2011) Prevention and schizophrenia-the role of dietary factors. Schizophr Bull 37: 272-283.
6. McGrath JJ, Eyles DW, Pedersen CB, Anderson C, Ko P, et al. (2010) Neonatal vitamin D status and risk of schizophrenia: A population-based case-control study. Arch Gen Psychiatry 67: 889-894.
7. McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, et al. (2004) Vitamin D supplementation during the first year of life and risk of schizophrenia: A finnish birth cohort study. Schizophr Res 67: 237-245.
8. Hedelin M, Lof M, Olsson M, Lewander T, Nilsson B, et al. (2010) Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population. BMC Psychiatry 10: 38.
9. Brown AJ, Dusso A, Slatopolsky E, (1999) Vitamin D. Am J Physiol 277: 157-175.
10. Mundy GR, Guise TA, (1999) Hormonal control of calcium homeostasis. Clin Chem 45: 1347-1352.
11. Golding J, Pembrey M, Jones R, ALSPAC Study Team (2001) ALSPAC-the avon longitudinal study of parents and children. I. study methodology. Paediatr Perinat Epidemiol 15: 74-87.
12. Zammit S, Horwood J, Thompson A, Thomas K, Menezes P, et al. (2008) Investigating if psychosis-like symptoms (PLIKS) are associated with family history of schizophrenia or paternal age in the ALSPAC birth cohort. Schizophr Res 104: 279-286.
13. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC, (1996) Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. the national comorbidity survey. Arch Gen Psychiatry 53: 1022-1031.
14. Horwood J, Salvi G, Thomas K, Duffy L, Gunnell D, et al. (2008) IQ and non-clinical psychotic symptoms in 12-year-olds: Results from the ALSPAC birth cohort. Br J Psychiatry 193: 185-191.
15. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME, (2000) NIMH diagnostic interview schedule for children version IV (NIMH DISC-IV): Description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 39: 28-38.
16. World Health Organisation (1994) Schedules for clinical assessment in neuropsychiatry. World Health Organization, Division of Mental Health. 331 pages.
17. Hernan MA, Hernandez-Diaz S, Werler MM, Mitchell AA, (2002) Causal knowledge as a prerequisite for confounding evaluation: An application to birth defects epidemiology. Am J Epidemiol 155: 176-184.
18. Tanner J, (1962) Growth at adolescence. Oxford: Blackwell Scientific Publications. 325 p.
19. Wang Y, Jacobs EJ, McCullough ML, Rodriguez C, Thun MJ, et al. (2009) Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: Insights from simulations based on serum 25-hydroxyvitamin d. Am J Epidemiol 170: 88-94.
20. Karani VK, Berry D, Whittaker J, Power C, Hingorani AD, et al. (2010) Association between body mass index and 25-hydroxyvitamin D examined using a genetic approach-the 1958 british birth cohort. Longitudinal and Life Course Studies 1: 234.
21. Hypponen E, Fararouei M, Sovio U, Hartikainen AL, Pouta A, et al. (2011) High-dose vitamin D supplements are not associated with linear growth in a large finnish cohort. J Nutr 141: 843-848.
22. Finch JL, Brown AJ, Slatopolsky E, (1999) Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone. J Am Soc Nephrol 10: 980-985.
23. Glendenning P, Chew GT, Seymour HM, Gillett MJ, Goldswain PR, et al. (2009) Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone 45: 870-875.
24. Houghton LA, Vieth R, (2006) The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 84: 694-697.
25. Tolppanen AM, Fraser A, Fraser WD, Lawlor DA, (2012) Risk factors for variation in 25-hydroxyvitamin D3 and D2 concentrations and vitamin D deficiency in children. J Clin Endocrinol Metab 97: 1202-1210.
26. Almeras L, Eyles D, Benech P, Laffite D, Villard C, et al. (2007) Developmental vitamin D deficiency alters brain protein expression in the adult rat: Implications for neuropsychiatric disorders. Proteomics 7: 769-780.
27. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ, (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29: 21-30.
28. Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F, (2003) Vitamin D3 and brain development. Neuroscience 118: 641-653.
29. Eyles DW, Feron F, Cui X, Kesby JP, Harms LH, et al. (2009) Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology 34: S247-S257.
30. McGrath J, (2011) Migrant status, vitamin D and risk of schizophrenia. Psychol Med 41: 892-893.
31. McCann JC, Ames BN, (2008) Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 22: 982-1001.
32. Dhossche D, Ferdinand R, Van der Ende J, Hofstra MB, Verhulst F, (2002) Diagnostic outcome of self-reported hallucinations in a community sample of adolescents. Psychol Med 32: 619-627.
33. Dominguez MD, Wichers M, Lieb R, Wittchen HU, van Os J, (2011) Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: An 8-year cohort study. Schizophr Bull 37: 84-93.
34. Lincoln TM, (2007) Relevant dimensions of delusions: Continuing the continuum versus category debate. Schizophr Res 93: 211-220.
35. Rossler W, Riecher-Rossler A, Angst J, Murray R, Gamma A, et al. (2007) Psychotic experiences in the general population: A twenty-year prospective community study. Schizophr Res 92: 1-14.
36. Rai D, Skapinakis P, Wiles N, Lewis G, Araya R, (2010) Common mental disorders, subthreshold symptoms and disability: Longitudinal study. Br J Psychiatry 197: 411-412.
37. Davey Smith G, Ebrahim S, (2003) 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32: 1-22.
38. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G, (2008) Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat Med 27: 1133-1163.
39. McGrath JJ, Saha S, Burne TH, Eyles DW, (2010) A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol 121: 471-477.
40. McGrath J, (2010) Is it time to trial vitamin D supplements for the prevention of schizophrenia? Acta Psychiatr Scand 121: 321-324.
41. Schram MT, Trompet S, Kamper AM, de Craen AJ, Hofman A, et al. (2007) Serum calcium and cognitive function in old age. J Am Geriatr Soc 55: 1786-1792.
42. Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP, (2010) Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 19: 927-931.